Related references
Note: Only part of the references are listed.2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance
Marina Cuchel et al.
EUROPEAN HEART JOURNAL (2023)
International Atherosclerosis Society guidance for implementing best practice in the care of familial hypercholesterolaemia
Gerald F. Watts et al.
NATURE REVIEWS CARDIOLOGY (2023)
How does cholesterol burden change the case for investing in familial hypercholesterolaemia? A cost-effectiveness analysis
Rita Faria et al.
ATHEROSCLEROSIS (2023)
Prevalence of FH-Causing Variants and Impact on LDL-C Concentration in European, South Asian, and African Ancestry Groups of the UK Biobank-Brief Report
Jasmine Gratton et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2023)
Madam Irma
Helene Vaillant-Roussel et al.
EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE (2022)
Paediatric familial hypercholesterolaemia screening in Europe: public policy background and recommendations
Samuel S. Gidding et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2022)
Childhood Cardiovascular Risk Factors and Adult Cardiovascular Events
David R. Jacobs et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
ANGPTL3 Inhibition With Evinacumab Results in Faster Clearance of IDL and LDL apoB in Patients With Homozygous Familial Hypercholesterolemia-Brief Report
Laurens F. Reeskamp et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2021)
100,000 Genomes Pilot on Rare-Disease Diagnosis in Health Care - Preliminary Report
Damian Smedley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Reaching detection targets in familial hypercholesterolaemia: Comparison of identification strategies
David S. Wald et al.
ATHEROSCLEROSIS (2020)
Association of Monogenic vs Polygenic Hypercholesterolemia With Risk of Atherosclerotic Cardiovascular Disease
Mark Trinder et al.
JAMA CARDIOLOGY (2020)
Reducing cardiovascular disease risk among families with familial hypercholesterolaemia by improving diet and physical activity: a randomised controlled feasibility trial
Fiona Jane Kinnear et al.
BMJ OPEN (2020)
Lipoprotein apheresis efficacy, challenges and outcomes: A descriptive analysis from the UK Lipoprotein Apheresis Registry, 1989-2017
Alison Pottle et al.
ATHEROSCLEROSIS (2019)
Current management of children and young people with heterozygous familial hypercholesterolaemia - HEART UK statement of care
Uma Ramaswami et al.
ATHEROSCLEROSIS (2019)
20-Year Follow-up of Statins in Children with Familial Hypercholesterolemia
I. K. Luirink et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Longitudinal effect of 20-year infancy-onset dietary intervention on food consumption and nutrient intake: the randomized controlled STRIP study
Laurie A. Matthews et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2019)
Survival in homozygous familial hypercholesterolaemia is determined by the on-treatment level of serum cholesterol
Gilbert R. Thompson et al.
EUROPEAN HEART JOURNAL (2018)
Coronary heart disease mortality in treated familial hypercholesterolaemia: Update of the UK Simon Broome FH register
S. E. Humphries et al.
ATHEROSCLEROSIS (2018)
Universal screening at age 1-2 years as an adjunct to cascade testing for familial hypercholesterolaemia in the UK: A cost-utility analysis
Ailsa J. McKay et al.
ATHEROSCLEROSIS (2018)
The UK Paediatric Familial Hypercholesterolaemia Register: Statin-related safety and 1-year growth data
Steve E. Humphries et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2018)
The UK Paediatric Familial Hypercholesterolaemia Register: preliminary data
Uma Ramaswami et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2017)
Cost effectiveness of cascade testing for familial hypercholesterolaemia, based on data from familial hypercholesterolaemia services in the UK
Marion Kerr et al.
EUROPEAN HEART JOURNAL (2017)
ANGPTL3 Inhibition in Homozygous Familial Hypercholesterolemia
Daniel Gaudet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Estimating the prevalence of heterozygous familial hypercholesterolaemia: a systematic review and meta-analysis
Leo E. Akioyamen et al.
BMJ OPEN (2017)
Long-term treatment with evolocumab added to conventional drug therapy, with or without apheresis, in patients with homozygous familial hypercholesterolaemia: an interim subset analysis of the open-label TAUSSIG study
Frederick J. Raal et al.
LANCET DIABETES & ENDOCRINOLOGY (2017)
How many patients with a monogenic diagnosis of Familial Hypercholesterolemia are currently known in UK lipid clinics?
K. Haralambos et al.
ATHEROSCLEROSIS SUPPLEMENTS (2017)
Long-Term Efficacy and Safety of the Microsomal Triglyceride Transfer Protein Inhibitor Lomitapide in Patients With Homozygous Familial Hypercholesterolemia
Dirk J. Blom et al.
CIRCULATION (2017)
Screening for familial hypercholesterolaemia in childhood: Avon Longitudinal Study of Parents and Children (ALSPAC)
Marta Futema et al.
ATHEROSCLEROSIS (2017)
HEART UK statement on the management of homozygous familial hypercholesterolaemia in the United Kingdom
Michael France et al.
ATHEROSCLEROSIS (2016)
The lifelong socioeconomic disadvantage of single-mother background - the Helsinki Birth Cohort study 1934-1944
H. Maiju Mikkonen et al.
BMC PUBLIC HEALTH (2016)
Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients With Severe Hypercholesterolemia
Amit V. Khera et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Child-Parent Familial Hypercholesterolemia Screening in Primary Care
David S. Wald et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment
Albert Wiegman et al.
EUROPEAN HEART JOURNAL (2015)
Emerging PCSK9 inhibitors for treating dyslipidaemia: buttressing the gaps in coronary prevention
Michael M. Page et al.
EXPERT OPINION ON EMERGING DRUGS (2015)
Mortality after Parental Death in Childhood: A Nationwide Cohort Study from Three Nordic Countries
Jiong Li et al.
PLOS MEDICINE (2014)
Exome Sequencing and Directed Clinical Phenotyping Diagnose Cholesterol Ester Storage Disease Presenting as Autosomal Recessive Hypercholesterolemia
Nathan O. Stitziel et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2013)
Statin treatment of children with familial hypercholesterolemia - Trying to balance incomplete evidence of long-term safety and clinical accountability: Are we approaching a consensus?
Alpo Vuorio et al.
ATHEROSCLEROSIS (2013)
Description of a Large Family with Autosomal Dominant Hypercholesterolemia Associated with the APOE p.Leu167del Mutation
Marie Marduel et al.
HUMAN MUTATION (2013)
Family policy, family structure, and children's educational achievement
Gillian Hampden-Thompson
SOCIAL SCIENCE RESEARCH (2013)
Adult presentations of medium-chain acyl-CoA dehydrogenase deficiency (MCADD)
T. F. Lang
JOURNAL OF INHERITED METABOLIC DISEASE (2009)
Child-parent screening for familial hypercholesterolaemia: screening strategy based on a meta-analysis
David S. Wald et al.
BMJ-BRITISH MEDICAL JOURNAL (2007)
Phenomenology and correlates of complicated grief in children and adolescents
Nadine M. Melhem et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2007)
Genetic causes of familial hypercholesterolaemia in patients in the UK: relation to plasma lipid levels and coronary heart disease risk
S. E. Humphries et al.
JOURNAL OF MEDICAL GENETICS (2006)
Arterial intima-media thickness in children heterozygous for familial hypercholesterolaemia
A Wiegman et al.
LANCET (2004)
Psychological impact of genetic testing for familial hypercholesterolemia within a previously aware population: A randomized controlled trial
T Marteau et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2004)
Efficacy and safety of statin therapy in children with familial hypercholesterolemia -: A randomized controlled trial
A Wiegman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia
D Marks et al.
ATHEROSCLEROSIS (2003)
Share Paper
